Skip to main content
Clinical Trials/NCT04491292
NCT04491292
Recruiting
N/A

Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce

M.D. Anderson Cancer Center1 site in 1 country20,000 target enrollmentMay 18, 2020

Overview

Phase
N/A
Intervention
Questionnaire Administration
Conditions
COVID-19 Infection
Sponsor
M.D. Anderson Cancer Center
Enrollment
20000
Locations
1
Primary Endpoint
Change in stress-related outcomes
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may allow for more comprehensive actions to be taken to protect the mental health of employees.

Detailed Description

PRIMARY OBJECTIVE: I. To assess psychosocial and stress-related outcomes in employees at MD Anderson Cancer Center during and post the COVID-19 pandemic. SECONDARY OBJECTIVE: I. To identify demographic and occupational factors associated with COVID-19 related psychosocial and stress outcomes. OUTLINE: Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.

Registry
clinicaltrials.gov
Start Date
May 18, 2020
End Date
April 30, 2026
Last Updated
3 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • MD Anderson employees

Exclusion Criteria

  • Not provided

Arms & Interventions

Observational (questionnaire)

Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.

Intervention: Questionnaire Administration

Outcomes

Primary Outcomes

Change in stress-related outcomes

Time Frame: Baseline up to 3 months after the outbreak ends

Will be assessed using the questions administered in the second part of the questionnaire, specifically, the 20 stress-related items and the IES. Summary statistics will be calculated for each of the individual 20 stress-related questions. The total distress score as well as the scores for the intrusion and avoidance subscales will be calculated and also summarized via descriptive statistics. Summary statistics will be calculated separately for data collected during the pandemic and at follow-up, as well as for change from pandemic to follow-up. Ninety-five percent confidence intervals will be calculated for the mean of the change scores.

Change in psychosocial outcomes

Time Frame: Baseline up to 3 months after the outbreak ends

Will be assessed using the questions administered in the second part of the questionnaire, specifically, the 20 stress-related items and the Impact of Event Scale (IES). Summary statistics will be calculated for each of the individual 20 stress-related questions. The total distress score as well as the scores for the intrusion and avoidance subscales will be calculated and also summarized via descriptive statistics. Summary statistics will be calculated separately for data collected during the pandemic and at follow-up, as well as for change from pandemic to follow-up. Ninety-five percent confidence intervals will be calculated for the mean of the change scores.

Secondary Outcomes

  • Demographic and occupational factors associated psychological and stress-related outcomes(Up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials